» news archive
26 November, 2009 » ELARA Pharmaceuticals receives EUR 4.6 Million funding and names Dr. Christof Antz as Chief Business Officer. Financing supports development of lead candidate for the treatment of Multiple Myeloma and other cancers to IND.
» ELARA Pharmaceuticals erhält Finanzierung in Höhe von 4,6 Millionen Euro und ernennt Dr. Christof Antz zum Chief Business Officer Finanzmittel ermöglichen die Entwicklung eines innovativen Medikamentenkandidaten zur Behandlung des Multiplen Myeloms und anderer Krebserkrankungen bis zur Klinik
---
» Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
© 2009, Elara Pharmaceuticals. All rights reserved.